ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SNG Synairgen Plc

4.51
-0.135 (-2.91%)
Last Updated: 11:53:49
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.135 -2.91% 4.51 4.41 4.99 4.53 4.51 4.53 189,892 11:53:49
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.51 9.35M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.65p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,345,000 shares in issue. The market capitalisation of Synairgen is £9.35 million. Synairgen has a price to earnings ratio (PE ratio) of -0.51.

Synairgen Share Discussion Threads

Showing 15376 to 15399 of 99175 messages
Chat Pages: Latest  619  618  617  616  615  614  613  612  611  610  609  608  Older
DateSubjectAuthorDiscuss
21/7/2020
07:06
No they didn't they sold 4.7% on Friday they missed out on £10 million more profit. Now thats bad timing !!!
whatsthepoint
21/7/2020
07:06
Acacia have screwed up big time LOL!
vikingwarrier
21/7/2020
07:04
Arc nearly out !! Made some serious cash yesterday
amaretto1
21/7/2020
07:04
RNS !! Fincap games again
amaretto1
21/7/2020
07:03
May I join too please , only holding 10k but have held for quite a while .
tardelli2
21/7/2020
07:02
Morning,Very new here (as in yesterday new)Fantastic story for all those long-termers so congratulations to you. I'm delighted at getting in at 105 (negotiated trade placed at 0735 yesterday and not executed for almost an hour after!) some nailbiting moments there!!I would love to sit at the table and be part of a more educated, moderated discussion so, if I qualify for a coin to sit at the table Nobby I would be very grateful. Cheers
maverick82
21/7/2020
06:57
And if I may sir I would also like to sit at the table
crookie3634
21/7/2020
06:55
I'd like to join please
jjmills56
21/7/2020
06:54
Yes strange comments on the BBC article, not registered and need to see the protocol? It’s not difficult to find the trial was registered as a clinical trial and the protocol is laid out for anyone to see. Strange that someone would report it and also someone of such standing would make such ill informed comments, poor. Be interesting to see how this week plays out, more news to come if they get regulatory approval and announce the tie up with a big pharmaceutical then we are in business. Then there is the international interest, RM is going to be busy! I think yesterday is just the start and more news flow this week. Would be nice to understand the home trial progress I know it is not getting the numbers but a month in now we must be due an update.
crookie3634
21/7/2020
06:54
Welcome Freedosh.
dovey21
21/7/2020
06:51
You all have coins. Now click on the new thread entitled SNG001; a potential treatment for Covid 19 and apply to join the Guild.
nobbygnome
21/7/2020
06:22
RMC100 'what's the next big thing' that is the $6m question and one we are all asking. I think it could be Evgen, this little company has not happened yet even though they got funding from LifeArc for their SFX-01. They also plan to produce a food additive for mass consumption. Mind you they have no CEO right now, the right man could take this little minnow to the moon.

SFX-01 to be evaluated in COVID-19 trial

Evgen Pharma plc (AIM: EVG), the clinical stage drug development company, is delighted to announce participation in the recently notified funding initiative for COVID-19 clinical trials by the medical research charity, LifeArc. Under this scheme Evgen's lead product candidate, SFX-01, has been selected for evaluation in a randomised Phase II/III trial to be sponsored by the University of Dundee ("Dundee"). The trial will investigate whether SFX-01 can reduce the severity, or prevent the onset of, acute respiratory distress syndrome ("ARDS") associated with COVID-19, thus reducing the need for invasive patient ventilation and potentially improving recovery times.

czar
21/7/2020
05:27
Yes please nobby! Can you send me a coin please thank you! Regards!
bmwman3
21/7/2020
04:32
He did already with remdesivir
dave444
Chat Pages: Latest  619  618  617  616  615  614  613  612  611  610  609  608  Older

Your Recent History

Delayed Upgrade Clock